Diabetes & CV Disease
Sort by:
24th Annual Heart Failure 2020: an Update on Therapy
SGLT2 Inhibitors as a Treatment for Heart Failure
FEATURING
Uri Elkayam
- 225 views
- August 27, 2020
- 2
Cardiometabolic Health Congress (CMHC)
ACC Guidelines on Diabetes, CVD & CKD: Will SGLT-2i Become a SoC in HFrEF? What Are the Major Ongoing CKD Trials?
FEATURING
Stephen D. Wiviott
- 376 views
- September 22, 2020
- 3
Cardiometabolic Health Congress (CMHC)
Q&A on Cardiorenal Protection With SGLT-2 Inhibitors in T2DM and Beyond
- 239 views
- September 22, 2020
- 2
Cleveland Clinic Heart, Vascular and Thoracic Institute
Tall RoundsĀ®: Impact of Bariatric Surgery on Cardiovascular Health
FEATURING
ALI AMINIAN
- 265 views
- October 5, 2020
- 1
The North American Thrombosis Forum (NATF)
Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use Empagliflozin, Dapagliflozin and Antiarrhythmic Drugs? What Are the Guidelines for Patients with AFib and Elective PCI or ACS? When to Perform Catheter Ablation?
FEATURING
Christian Ruff
- 603 views
- October 15, 2020
- 6
Stanford Medicine
Managing Diabetes During COVID-19: How to Do Motivational Interviewing Via Telehealth?
FEATURING
Eleni Sheehan
- 34 views
- November 16, 2020
Stanford Medicine
Nuts & Bolts of Remote Insulin Adjustment and Diabetes Education
FEATURING
Eileen Egan
- 539 views
- November 16, 2020
- 1